Literature DB >> 23542036

Regulation of the MDR1 promoter by E2F1 and EAPP.

Peter Andorfer1, Hans Rotheneder.   

Abstract

Multidrug resistance (MDR), one of the main reasons for diminishing efficacy of prolonged chemotherapy, is frequently caused by the elevated expression of the ABCB1/MDR1 gene encoding PGP (P-glycoprotein). EAPP (E2F Associated PhosphoProtein) is a frequently overexpressed protein in human tumor cells. It inhibits apoptosis in a p21-dependent manner. We show here that EAPP stimulates the MDR1 promoter resulting in higher PGP levels. Independently of EAPP, E2F1 also increases the activity of the MDR1 promoter. Co-expression of pRb inhibits E2F1-, but not EAPP-dependent promoter activation. The upregulation of PGP might contribute to the survival of tumor cells during chemotherapy and worsen the prognosis for the patient.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23542036     DOI: 10.1016/j.febslet.2013.03.026

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

Review 1.  Disrupting P-glycoprotein function in clinical settings: what can we learn from the fundamental aspects of this transporter?

Authors:  Francisco S Chung; Jayson S Santiago; Miguel Francisco M De Jesus; Camille V Trinidad; Melvin Floyd E See
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

2.  Expression of multidrug-resistance associated proteins in human retinoblastoma treated by primary enucleation.

Authors:  Li-Juan Tang; Li-Jun Zhou; Wen-Xin Zhang; Jian-Yan Lin; Yong-Ping Li; Hua-Sheng Yang; Ping Zhang
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

3.  MicroRNA 130b enhances drug resistance in human ovarian cancer cells.

Authors:  Can Zong; Jun Wang; Tie-Mei Shi
Journal:  Tumour Biol       Date:  2014-08-26

4.  Identification of trichlormethiazide as a Mdr1a/b gene expression enhancer via a dual secretion-based promoter assay.

Authors:  Sarina Schulze; Sven Reinhardt; Christian Freese; Ulrich Schmitt; Kristina Endres
Journal:  Pharmacol Res Perspect       Date:  2015-01-05

5.  MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.

Authors:  Shuo Chen; Jin-Wen Jiao; Kai-Xuan Sun; Zhi-Hong Zong; Yang Zhao
Journal:  Drug Des Devel Ther       Date:  2015-09-16       Impact factor: 4.162

6.  Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorubicin by downregulation of MDR-1 expression.

Authors:  Zhen Liu; Zhi-Jun Duan; Jiu-Yang Chang; Zhi-Feng Zhang; Rui Chu; Yu-Ling Li; Ke-Hang Dai; Guang-Quan Mo; Qing-Yong Chang
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

7.  microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells.

Authors:  Shuo Chen; Xi Chen; Yin-Ling Xiu; Kai-Xuan Sun; Zhi-Hong Zong; Yang Zhao
Journal:  J Ovarian Res       Date:  2014-08-31       Impact factor: 4.234

8.  Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.

Authors:  Lin-Hai Yan; Wei-Yuan Wei; Wen-Long Cao; Xiao-Shi Zhang; Yu-Bo Xie; Qiang Xiao
Journal:  BMC Cancer       Date:  2014-12-03       Impact factor: 4.430

9.  MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1.

Authors:  Kai-Xuan Sun; Jin-Wen Jiao; Shuo Chen; Bo-Liang Liu; Yang Zhao
Journal:  J Ovarian Res       Date:  2015-12-02       Impact factor: 4.234

10.  Expression of P-glycoprotein in human retinoblastoma and its clinical significance.

Authors:  Sumita Sethi; Manzoor Ahmad Malik; Sandeep Goswami; Parul Saxena; Arpna Srivastava; Seema Kashyap; Neelam Pushker; Mandeep Singh Bajaj; Sameer Bakhshi; Jasbir Kaur
Journal:  Tumour Biol       Date:  2014-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.